The Board of Directors of CanSino Biologics Inc. has authorized a buyback plan on January 23, 2022.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
22.45 HKD | -1.75% | +5.15% | -4.67% |
05-21 | Cansino Biologics Invests 160 Million Yuan in China Bohai Bank’s Structured Deposits | MT |
04-29 | CanSino Biologics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.67% | 1.19B | |
-2.42% | 90.75B | |
-1.97% | 39.03B | |
-15.47% | 31.85B | |
+61.28% | 26.26B | |
-22.81% | 14.13B | |
-8.82% | 12.87B | |
-11.77% | 11.6B | |
-45.97% | 10.91B | |
+3.30% | 8.89B |
- Stock Market
- Equities
- 6185 Stock
- News CanSino Biologics Inc.
- CanSino Biologics Inc. authorizes a Buyback Plan.